OA13.03 Perioperative Durvalumab for Resectable NSCLC (R-NSCLC): Updated Outcomes from the Phase 3 AEGEAN Trial

John V. Heymach, David Harpole, T. Mitsudomi, Janis M. Taube, Shugeng Gao, László Urbán, Jin‐Hyoung Kang, Francesco Orlandi, Jerónimo Rafael Rodríguez‐Cid, Bartomeu Massutí, Leticia Léon Mateos, Giulia Pasello, Quincy S. Chu, Jarosław Kołb-Sielecki, M Nakata, Mike Aperghis, Helen Mann, Tamer M. Fouad, Gary J. Doherty, Martin Reck